Viewing Study NCT05679258


Ignite Creation Date: 2025-12-25 @ 12:12 AM
Ignite Modification Date: 2026-01-25 @ 8:58 AM
Study NCT ID: NCT05679258
Status: COMPLETED
Last Update Posted: 2024-06-28
First Post: 2022-12-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX15 With Daratumumab in Male Subjects
Sponsor: Shanghai Henlius Biotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module